Results 11 to 20 of about 12,790 (219)
Tirofiban for Preventing Early Neurological Deterioration in Acute Ischemic Stroke Within 48 Hours of Onset: Evidence From a Dual-Method Analysis Using Propensity Score Matching and Multivariable Regression. [PDF]
Previous studies have shown that tirofiban may reduce the risk of early neurological deterioration within 24 h after symptom onset in patients with acute ischemic stroke (AIS). However, evidence on its efficacy beyond this time window is limited. This study suggests that tirofiban may still confer potential therapeutic benefits in AIS patients without ...
Wen Q +13 more
europepmc +2 more sources
Tirofiban on First-Pass Recanalization in Acute Stroke Endovascular Thrombectomy: The OPTIMISTIC Randomized Clinical Trial. [PDF]
Lin L +20 more
europepmc +2 more sources
Objective: We aimed to develop an optimal protocol for failed mechanical thrombectomy (MT) in cases of emergent large vessel occlusion (ELVO) with intracranial atherosclerosis (ICAS).
Yun Ho Noh +11 more
doaj +1 more source
Objective To explore the feasibility of tirofiban, a platelet surface glycoprotein (GP)Ⅱb/Ⅲa receptor antagonist intervene in transfusion-related acute lung injury (TRALI), by inhibiting platelet activation and by preventing platelet and neutrophil ...
Xin YUAN +6 more
doaj +1 more source
To investigate the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris (UA).
Li Deng +3 more
doaj +1 more source
Local tirofiban infusion for remnant stenosis in large vessel occlusion: tirofiban ASSIST study
Background Compared with embolic occlusions, intracranial atherosclerotic stenosis (ICAS)-related large vessel occlusions (LVOs) often require rescue treatment following mechanical thrombectomy (MT).
Yong-Won Kim +11 more
doaj +1 more source
Purpose: Tirofiban administration to acute ischemic stroke patients undergoing mechanical thrombectomy with preceding intravenous thrombolysis remains controversial.
Gaoting Ma +20 more
doaj +1 more source
Objective: To evaluate the efficacy and safety of tirofiban for patients with acute ischemic stroke (AIS), especially posterior circulation stroke (PCS).Methods: We enrolled consecutive patients with AIS who suffered large artery occlusion (LAO) and ...
Lingxin Cai +8 more
doaj +1 more source
Blood Pressure Variability and 90-Day Functional Outcome in Branch Atheromatous Disease-Related Stroke: A Multicenter Prospective Study. [PDF]
ABSTRACT Branch atheromatous disease (BAD)‐related stroke shows distinct prognostic features from other stroke subtypes, with modifiable prognostic factors remaining inconclusive. The present research investigated the association between systolic blood pressure variability (BPV) and 90‐day functional outcomes of BAD‐related stroke.
Zhou Y +7 more
europepmc +2 more sources
Safety and efficacy of tirofiban after intravenous thrombolysis with urokinase in patients with acute ischemic stroke. [PDF]
Qu D +7 more
europepmc +3 more sources

